Abstract
Breast cancer is the most common cancer in women [1], and failure to diagnose it in a timely manner has been documented as the most common reason for a successful medical malpractice claim [2, 3]. Knowledge of the common allegations made when a malpractice suit is filed for failure to diagnose breast cancer can provide insight into the risk management of a physician’s practice and simultaneously minimize errors in patient care. Many physicians are unaware of the legal process involved in a malpractice suit until it affects them or a close colleague. At this point, an objective perspective is often impossible. Nonetheless, it is inevitable that many, if not most, physicians will find themselves a defendant in a medical malpractice suit at some point in their career for a less-than-perfect patient outcome, whether medical negligence has occurred or not. This chapter is intended to outline the common allegations of misdiagnosis or mismanagement of breast cancer, to review the process of legal proceedings common to a medical malpractice suit, to review the issues likely to arise in the defense of a case, and to provide recommendations on the steps to take when facing malpractice litigation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin. 58:71–96
Physician’s Insurance Association of America (1995) Breast cancer study. PIAA, Washington, DC
Physician’s Insurance Association of America (2002) Breast cancer study. PIAA, Washington, DC
Physician’s Insurance Association of America (1990) Breast cancer study. PIAA, Washington, DC
Physician’s Insurance Association of America (1995) Data sharing reports, executive summary. PIAA, Washington, DC
Roberts RG (2003) Seven reasons family doctors get sued and how to reduce your risk. Fam Pract Manag. 10(3):29–34
Kern KA. Medicolegal analysis of the delayed diagnosis of cancer in 338 cases in the United States. Arch Surg. 1994;129(4):397–403; discussion 4
Arnold R, Klingman R (1995) Medical malpractice liability for errors in breast cancer diagnosis and treatment. In: Donegan W, Spratt J (eds) Cancer of the Breast., 4th edn. W.B. Saunders, Philadelphia, pp 795–808
Anderson B, Cacioppo J (1995) Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Social Psychol. 34:33–52
Lauver D (1994) Care-seeking behavior with breast cancer symptoms in Caucasian and African-American women. Res Nurs Health. 17(6):421–31
Kacmar D (1994) The impact of computerized medical literature databases on medical malpractice litigation: time for another Helling vs. Carey wake up call? Ohio St LJ. 58:617
Furrow B, Greany T, Johnson S, Jos T, Schartz R (1995) Health law. West, St. Paul, MN
Prosser W (1978) Law of torts. West, St. Paul, MN
Mastroianni AC (2006) Liability, regulation and policy in surgical innovation: the cutting edge of research and therapy. Health Matrix Clevel. 16(2):351–442
Osuch JR, Bonham VL (1994) The timely diagnosis of breast cancer. Principles of risk management for primary care providers and surgeons, Cancer. 74(Suppl 1):271–8
Rigelhaupt J (2000) What constitutes patient-physician relationship for malpractice purposes. ALR. 17:132
Glicklich v Spievack, 16 MASS App 488:1983
Allen C (2003) Loss of Chance in Wyoming: alive, but for how long? Wyo L Rev. 6:533–58
Sandbar S, Gibofsky A, Firestone M, LeBlang T (1995) Legal medicine. Mosby, St. Louis
Schwartz V, Kelly K, Partlett D (eds) (2005) Torts case and materials., 11th edn. Foundation, Stamford. Connecticut
King R (1999) Reconciling the exercise of judgement and the objective standard of care in medical malpractice. Okla L Rev. 52:49–84
Hines N (2006) Why technology provides compelling reasons to apply a Daubert analysis to the legal standard of care in medical malpractice cases. Duke Law Technol Rev.
Evers v. Dollinger, 95 N.J. 399; 1984
JH G (1993) The Evers case: 1984 decision has lasting impact. N Jersey Med. 90:536–7
Anon. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. CMAJ. 1998;158(Suppl 3):S3–8
Ellis L (1993) Loss of chance as technique: toeing the line at fifty percent. Tex L Rev. 72:369–402
Walker V (1994) Direct inference in the lost chance cases: factfinding constraints under minimal fairness to parties. Hofstra L Rev. 23:247–307
National Institutes of Health Consensus Conference (1991) Treatment of early stage breast cancer. JAMA. 265:391–5
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN (2007) Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 608:1–22
ASCO Expert Panel (1998) 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. J Clin Oncol. 16:793–5
Ravdin PM, Siminoff LA, Davis GJ et al (2001) Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 19(4):980–91
Miller AB (1996) Fundamental issues in screening for cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention. Oxford University, New York, pp 1433–52
Freedman DA, Petitti DB, Robins JM (2004) On the efficacy of screening for breast cancer. Int J Epidemiol. 33(1):43–55
Humphrey LL, Helfand M, Chan BK, Woolf SH (2002) Breast cancer screening: a summary of the evidence for the U.S. preventive services task force. Ann Intern Med. 137(5 Part 1):347–60
Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res. 50:6130–8
Rutqvist LE, Wallgren A (1985) Long-term survival of 458 young breast cancer patients. Cancer. 55(3):658–65
Folkman MJ (2004) Angiogenesis and breast cancer. In: Bland KI, Copeland EM (eds) The breast comprehensive management of benign and malignant disorders., 3rd edn. Saunders, St. Louis, MO, pp. 563–86
MacDonald I (1951) Biological predeterminism in human cancer. Surg Gynecol Obstet. 92:443–52
Heuser L, Spratt JS, Polk HC Jr (1979) Growth rates of primary breast cancers. Cancer. 43(5):1888–94
Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC (1999) The natural history of breast carcinoma: what have we learned from screening? Cancer. 86(3):449–62
Kern K (2004) The delayed diagnosis of symptomatic breast cancer. In: Ba C (ed) The breast comprehensive management of benign and malignant disorders., 3rd edn Saunders, St. Louis, MO, pp 1597–628
Sainsbury R, Johnston C, Haward B (1999) Effect on survival of delays in referral of patients with breast cancer symptoms: a retrospective analysis. Lancet. 353(9159):1132–5
Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 353(9159):1119–26
McElhaney J (1987) McElhaney’s trial notebook., 2nd edn. American Bar Association, Chicago, pp 31–2
Anon. Tamoxifen for early breast cancer: an overview of the randomized trials. Early Breast Cancer Trialists’ Collaborative Group. Lancet. 1998;351(9114):1451–67
Black H (2004) Law dictionary., 8th edn. West, St. Paul, MN
Danner D, Varn L, Mathias S (1994) Medical malpractice: checklist and discovery. CBC, New York
Vidmar N (1995) Medical malpractice and the American Jury. The University of Michigan, Ann Arbor, MI
Ellerin I, Frieder M, Hillerich G. Handling a failure to diagnose breast cancer. Trial. 1996:31–7
Beckman HB, Markakis KM, Suchman AL, Frankel RM (1994) The doctor-patient relationship and malpractice. Lessons from plaintiff depositions. Arch Intern Med. 154(12):1365–70
Levinson W, Roter DL, Mullooly JP, Dull VT, Frankel RM (1997) Physician-patient communication. The relationship with malpractice claims among primary care physicians and surgeons. JAMA. 277(7):553–9
Shapiro RS, Simpson DE, Lawrence SL, Talsky AM, Sobocinski KA, Schiedermayer DL (1989) A survey of sued and nonsued physicians and suing patients. Arch Intern Med. 149(10):2190–6
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Osuch, J.R., Bonham, V.L. (2010). Medicolegal Pitfalls in Breast Cancer Diagnosis and Management. In: Jatoi, I., Kaufmann, M. (eds) Management of Breast Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69743-5_33
Download citation
DOI: https://doi.org/10.1007/978-3-540-69743-5_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69742-8
Online ISBN: 978-3-540-69743-5
eBook Packages: MedicineMedicine (R0)